Prestige Consumer Healthcare
(NYSE) PBH
Prestige Consumer Healthcare Financials at a Glance
Market Cap
$2.80B
Revenue (TTM)
$1.10B
Net Income (TTM)
$186.50M
EPS (TTM)
$3.78
P/E Ratio
15.66
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$59.22
Volume
24,712
Open
$60.20
Price
$59.22
Volume
24,712
Open
$60.20
Previous Close
$59.22
Daily Range
$58.90 - $60.63
52-Week Range
$57.25 - $89.37
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$59.22
Volume
24,712
Open
$60.20
Previous Close
$59.22
Daily Range
$58.90 - $60.63
52-Week Range
$57.25 - $89.37
PBH News
PBH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Prestige Consumer Healthcare
Industry
Pharmaceuticals
Sector
Health CareEmployees
600
CEO
Ronald M. Lombardi, MBA, CPA
Website
www.prestigebrands.comHeadquarters
Tarrytown, NY 10591, US
PBH Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
29%
Net Income Margin
17%
Return on Equity
10%
Return on Capital
10%
Return on Assets
5%
Earnings Yield
6.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.80B
Shares Outstanding
47.32M
Volume
24.71K
Short Interest
0.00%
Avg. Volume
417.57K
Financials (TTM)
Gross Profit
$634.46M
Operating Income
$336.77M
EBITDA
$361.99M
Operating Cash Flow
$251.51M
Capital Expenditure
$8.22M
Free Cash Flow
$243.29M
Cash & ST Invst.
$97.88M
Total Debt
$1.04B
Prestige Consumer Healthcare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$283.44M
-2.4%
Gross Profit
$157.37M
-2.3%
Gross Margin
55.52%
N/A
Market Cap
$2.80B
N/A
Market Cap/Employee
$4.67M
N/A
Employees
600
N/A
Net Income
$46.70M
-23.5%
EBITDA
$80.08M
-18.7%
Quarterly Fundamentals
Net Cash
$1.02B
-4.2%
Accounts Receivable
$190.46M
+13.9%
Inventory
$163.59M
+8.0%
Long Term Debt
$1.07B
+4.9%
Short Term Debt
$8.63M
+24.8%
Return on Assets
5.34%
N/A
Return on Invested Capital
9.61%
N/A
Free Cash Flow
$75.26M
+18.5%
Operating Cash Flow
$78.29M
+20.3%